Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation (Q35136228)

6 August 2017

1 reference

title

Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

Ijaz A Khan

1

1 reference

6 August 2017

Nirav J Mehta

series ordinal

2

1 reference

6 August 2017

Ramesh M Gowda

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

International Journal of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

89

1 reference

6 August 2017

issue

2-3

1 reference

6 August 2017

page(s)

239-248

1 reference

Short-term effect of atrial fibrillation on atrial contractile function in humans

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900477-1

7 January 2021

10.1016/S0167-5273(02)00477-1

Identifiers

DOI

1 reference

release_pcvgmbkfrbha5cukyewsxgemjm

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pcvgmbkfrbha5cukyewsxgemjm

24 November 2022

mapped directly with Wikidata item

1 reference